| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012095 |
| Receipt No. | R000014134 |
| Official scientific title of the study | Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest (PBSCH) |
| Date of disclosure of the study information | 2013/10/25 |
| Last modified on | 2017/04/27 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest (PBSCH) | |
| Title of the study (Brief title) | Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest | |
| Region |
|
|
| Condition | |||
| Condition | Hematological malignancies | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | It is to compare efficiency, safety, operation between Spectra-Optia and Spectra-Auto (both from Terumo BCT). |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Numbers and efficiencies of collected CD34+ cells and mononuclear cells. Contaminated unnecessary cells Frequencies of adverse reactions. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Spectra-Optia will be chosen for peripheral blood stem cell harvest | |
| Interventions/Control_2 | Spectra-Auto will be chosen for peripheral blood stem cell harvest | |
| Interventions/Control_3 | Spectra-Optia and Spectra-Auto will be chosen for peripheral blood stem cell harvest at first and second days, respectively | |
| Interventions/Control_4 | Spectra-Auto and Spectra-Optia will be chosen for peripheral blood stem cell harvest at first and second days, respectively | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who will require autologous peripheral blood stem cell transplantation (PBSCT) or donors for allogeneic PBSCT will be eligible if they undergo PBSCH. Written informed consent is required, and enrollees should be 18 years or older. | |||
| Key exclusion criteria | Patients or donors without written informed consent will be excluded. | |||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Hitoshi Ohto |
| Organization | Fukushima Medical University |
| Division name | Department of Blood Transfusion and Transplantation Immunology |
| Address | 1 Hikariga-oka, Fukushima |
| TEL | 024-547-1536 |
| hit-ohto@fmu.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiko Ikeda |
| Organization | Fukushima Medical University |
| Division name | Department of Blood Transfusion and Transplantation Immunology |
| Address | 1 Hikariga-oka, Fukushima |
| TEL | 024-547-1536 |
| Homepage URL | |
| kazu-ike@fmu.ac.jp | |
| Sponsor | |
| Institute | Japan Society of Blood Transfusion and Cell Therapy |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Terumo BCT |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014134 |